{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:54:42Z","timestamp":1789167282925,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arcmed.2023.102914","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:45:52Z","timestamp":1700837152000},"page":"102914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Acromegaly and Cancer: An Update"],"prefix":"10.1016","volume":"54","author":[{"given":"Karina","family":"Danilowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0817-2734","authenticated-orcid":false,"given":"Soledad","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102914_bib0001","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11102-015-0701-2","article-title":"Incidence and prevalence of acromegaly in a large US health plan database","volume":"19","author":"Burton","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0003","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"Acromegaly","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2023.102914_bib0004","first-page":"414","article-title":"Growth hormone, insulin like growth factor system, and carcinogenesis","volume":"67","author":"Boguszewski","year":"2016","journal-title":"Endokrynologia Polska"},{"key":"10.1016\/j.arcmed.2023.102914_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11892-017-0838-7","article-title":"Diabetes in patients with acromegaly","volume":"17","author":"Hannon","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.arcmed.2023.102914_bib0006","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dcS13-2001","article-title":"Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer","volume":"36","author":"Gallagher","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2023.102914_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle regi\u00f3n","volume":"12","author":"Alexander","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0008","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.arcmed.2023.102914_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.arcmed.2023.102914_bib0011","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors Influencing Mortality in Acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11102-015-0700-3","article-title":"The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study","volume":"19","author":"Varadhan","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0013","first-page":"414","article-title":"Growth hormone, insulin like growth factor system and carcinogenesis","volume":"67","author":"Boguszewski","year":"2016","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/538019","article-title":"Insulin-like growth factor system in cancer: Novel targeted therapies","volume":"2015","author":"Brahmkhatri","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.arcmed.2023.102914_bib0015","first-page":"12","article-title":"Regulation of proliferation and apoptosis by the insulin-like growth factor 1 receptor","volume":"1","author":"LeRoith","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2023.102914_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cen.14468","article-title":"Insulin-like growth factor 1, growth hormone and disease outcomes in acromegaly: A population study","volume":"95","author":"Thomas","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0017","doi-asserted-by":"crossref","first-page":"568","DOI":"10.20945\/2359-3997000000186","article-title":"Growth hormone in the tumor microenvironment","volume":"63","author":"Chesnokova","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0018","doi-asserted-by":"crossref","first-page":"e23028","DOI":"10.1530\/ERC-23-0028","article-title":"Non-pituitary GH regulation of the tissue microenvironment","volume":"30","author":"Chesnokova","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-1 on mortality in acromegaly","volume":"159","author":"Holdaway","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0021","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"10.1016\/j.arcmed.2023.102914_bib0022","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Italian Study Group of Acromegaly. Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinology"},{"key":"10.1016\/j.arcmed.2023.102914_bib0023","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly","volume":"90","author":"Kauppinen-Makelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-022-03275-6","article-title":"Trends in incidence and mortality risk for acromegaly in Norway: a cohort study","volume":"80","author":"Falch","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2023.102914_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-21-0729","article-title":"Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register","volume":"186","author":"Arnard\u00f3ttir","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0026","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0027","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: Ligands, binding proteins, and receptors","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0029","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.arcmed.2023.102914_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-1 seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2023.102914_bib0031","doi-asserted-by":"crossref","first-page":"e1092","DOI":"10.1210\/clinem\/dgad212","article-title":"IGF-1 and Risk of Morbidity and Mortality From Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg","volume":"108","author":"Mukama","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0032","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Acromegaly and cancer: An old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0033","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2017-02457","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0034","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1015713732717","article-title":"Acromegaly and cancer risk: a cohort in Sweden and Denmark","volume":"13","author":"Baris","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2023.102914_bib0035","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German Acromegaly Registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP-2020-0398","article-title":"The prevalence of cancer and its relation to disease activity in patients with acromegaly: two centers\u2019 experience","volume":"27","author":"Ucan","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2023.102914_bib0037","first-page":"3487","article-title":"Incidence of benign and malignant tumors in patients with acromegaly is increased: A nationwide population-based study","volume":"106","author":"Esposito","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0038","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1210\/jcem.86.7.7634","article-title":"Acromegaly and Cancer: A Problem","volume":"86","author":"Jenkins","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0040","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/en.2004-0225","article-title":"Growth hormone inhibits apoptosis in human colonic cancer cell lines: a effects of peroxisome proliferator activated receptor \u0263 ligands","volume":"45","author":"Bogazzi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2023.102914_bib0041","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2265.2005.02405.x","article-title":"Apoptosis is reduced in the colonic mucosa of acromegalic patients","volume":"63","author":"Bogazzi","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0042","doi-asserted-by":"crossref","first-page":"E3250","DOI":"10.1073\/pnas.1600561113","article-title":"Growth hormone is permissive for neoplastic colon growth","volume":"113","author":"Chesnokova","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102914_bib0043","first-page":"924","article-title":"Acromegaly and colorectal neoplasm: An Update","volume":"20","author":"Kasuki","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00390","article-title":"Colonic cancer and acromegaly","volume":"10","author":"Dworakowska","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10147-021-01895-y","article-title":"The prevalence of secondary neoplasms in acromegalic patients: possible preventive and\/or protective role of metformin","volume":"26","author":"Costa","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0046","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.14.3484","article-title":"Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis","volume":"14","author":"Rokkas","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0047","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2004-814150","article-title":"Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications","volume":"35","author":"Renehan","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.arcmed.2023.102914_bib0048","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/a-1913-7900","article-title":"Clinical characteristics and associated factors of colonic polyps in acromegaly","volume":"130","author":"Peng","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.arcmed.2023.102914_bib0049","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11102-014-0586-5","article-title":"The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines","volume":"18","author":"Lois","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1507\/endocrj.K07E-010","article-title":"The prevalence of benign and malignant tumors in patients with acromegaly at a single institute","volume":"55","author":"Kurimoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2023.102914_bib0051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.1997.1911029.x","article-title":"Acromegaly, colonic polyps and carcinoma","volume":"47","author":"Jenkins","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0052","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: A survey in Italy","volume":"24","author":"Terzolo","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0053","first-page":"169","article-title":"Riesgo aumentado de lesions col\u00f3nicas preneopl\u00e1sicas en acromegalia: studio multic\u00e9ntrico caso control. Resultados preliminaries","volume":"54","author":"Battistone","year":"2017","journal-title":"Rev Argent Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0054","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0055","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1210\/jc.2005-2500","article-title":"Identification of acromegalic patients at risk of developing colonic adenomas","volume":"91","author":"Bogazzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0056","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1371\/journal.pone.0104174","article-title":"Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?","volume":"9","author":"Reverter","year":"2014","journal-title":"PLos One"},{"key":"10.1016\/j.arcmed.2023.102914_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly- meta-analysis and systematic review","volume":"9","author":"Wolinski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2023.102914_bib0058","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jcem-67-5-973","article-title":"Thyroid volume and serum thyroglobulin levels in patients with acromegaly: Correlation with plasma insulin-like growth factor 1 levels","volume":"67","author":"Miyakawa","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0059","doi-asserted-by":"crossref","unstructured":"Vargas-Ortega G, Romero-Gameros CA, Rend\u00f3n-Macias ME, et\u00a0al. Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center. Growth Horm IGF Res 202;60\u201361:101431.","DOI":"10.1016\/j.ghir.2021.101431"},{"key":"10.1016\/j.arcmed.2023.102914_bib0060","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0344-0338(11)80895-2","article-title":"Insulin-like growth factor 1 (IGF-1) in multinodular goiters: a possible pathogenetic factor","volume":"190","author":"Maiorano","year":"1994","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.arcmed.2023.102914_bib0061","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves\u2019-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2023.102914_bib0062","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11102-018-0923-1","article-title":"Evaluation of the natural course of thyroid nodules in patients with acromegaly","volume":"22","author":"Dogansen","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0063","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1590\/S0004-27302012000500004","article-title":"Thyroid nodules in acromegaly","volume":"56","author":"Rogozinski","year":"2012","journal-title":"Arq Bras Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0064","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03343997","article-title":"Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study","volume":"25","author":"Gasperi","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2023.102914_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0066","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-012-0383-y","article-title":"Thyroid cancer in patients with acromegaly: a case-control study","volume":"16","author":"dos Santos","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0067","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0068","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11102-016-0744-z","article-title":"Complications of acromegaly: thyroid and colon","volume":"20","author":"Tirosh","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102914_bib0069","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4158\/EP-2019-0254","article-title":"No Benefit of dedicated thyroid nodule screening in patients with acromegaly","volume":"26","author":"Lai","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2023.102914_bib0071","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2265.1997.2561053.x","article-title":"Increased incidence of neoplasia in females with acromegaly","volume":"47","author":"Cheung","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2021.101378","article-title":"Prevalence of thyroid cancer in patients with acromgaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study","volume":"56","author":"Spricido","year":"2021","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.arcmed.2023.102914_bib0073","first-page":"567","article-title":"Disease activity may not affect the prognosis of coexisting thyroid cancer in acromegalic patients","volume":"128","author":"Gul","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.arcmed.2023.102914_bib0074","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40842-020-00113-4","article-title":"Acromegaly and thyroid cancer: analysis of evolution in a series of patients","volume":"6","author":"Danilowicz","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0075","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102914_bib0076","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espa\u00f1ol de Acromegalia, REA)","volume":"151","author":"Mestr\u00f3n","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.arcmed.2023.102914_bib0077","first-page":"3073","article-title":"The evaluation of breast findings detected through different visualisation techniques in acromegaly patients \u2014 a retrospective study","volume":"51","author":"Akhanl\u0131","year":"2021","journal-title":"Med Sci"},{"key":"10.1016\/j.arcmed.2023.102914_bib0078","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0079","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102914_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0081","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: Re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev. Endocr. Metab. Disord"},{"key":"10.1016\/j.arcmed.2023.102914_bib0082","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1590\/S0004-27302009000800009","article-title":"Prostate cancer and acromegaly","volume":"53","author":"Corr\u00eaa","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0083","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.32808","article-title":"Hormone-Related Diseases and Prostate Cancer: An English National Record Linkage Study","volume":"147","author":"Watts","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0084","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF01225264","article-title":"Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines","volume":"118","author":"Rotsch","year":"1992","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.arcmed.2023.102914_bib0085","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ijc.2910560618","article-title":"Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines","volume":"56","author":"Favoni","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0086","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/er.2018-00166","article-title":"Growth hormone's links to cancer","volume":"40","author":"Boguszewski","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2023.102914_bib0087","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0088","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: A 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0089","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0","article-title":"Acromegaly and gastrointestinal cancer","volume":"68","author":"Ron","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2023.102914_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/jc.2004-0240","article-title":"Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy","volume":"90","author":"Terzolo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102914_bib0091","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.2017.0001","article-title":"Thyroid lesions in patients with acromegaly - case-control study and update to the meta-analysis","volume":"68","author":"Woli\u0144ski","year":"2017","journal-title":"Endokrynol Pol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:15:06Z","timestamp":1741184106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0188440923001522"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102914","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acromegaly and Cancer: An Update","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102914"}}